A novel hypoxia-inducible factor (HIF) activated oncolytic adenovirus for cancer therapy

Oncogene

Volumn 22, Issue 14, 2003, Pages 2065-2072

  Post, Dawn E ^a   Van Meir, Erwin G ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

Adenovirus; Gene delivery; HIF; Hypoxia; Oncolysis; Tumor

Indexed keywords

ADENOVIRUS VECTOR; HYPOXIA INDUCIBLE FACTOR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CELL HYPOXIA; CELL POPULATION; CONTROLLED STUDY; CYTOLYSIS; DNA RESPONSIVE ELEMENT; DRUG DESIGN; GENE CONSTRUCT; GENE FUNCTION; GENE TARGETING; HUMAN; HUMAN CELL; HYPOXIA RESPONSIVE ELEMENT; PRIORITY JOURNAL; PROTEIN BINDING; SOLID TUMOR; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS REPLICATION;

ADENOVIRIDAE; BRAIN NEOPLASMS; CELL HYPOXIA; DNA-BINDING PROTEINS; GENE THERAPY; GENETIC VECTORS; GLIOMA; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NUCLEAR PROTEINS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

ADENOVIRIDAE;

EID: 0037509944     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206464     Document Type: Article

References (28)

1. Bett AJ, Krougliak V and Graham FL. (1995). Virus Res., 39, 75-82.
2. Boast K, Binley K, Iqball S, Price T, Spearman H, Kingsman S, Kingsman A and Naylor S. (1999). Hum. Gene Ther., 10, 2197-2208.
3. Brown JM. (2000). Mol. Med. Today, 6, 157-162.
4. Dachs GU, Patterson AV, Firth JD, Ratcliffe PJ, Townsend KM, Stratford IJ and Harris AL. (1997). Nat. Med., 3, 515-520.
5. Dery CV, Herrmann CH and Mathews MB. (1987). Oncogene, 2, 15-23.
6. Fueyo J, Gomez-Manzano C, Alemany R, Lee PS, McDonnell TJ, Mitlianga P, Shi YX, Levin VA, Yung WK and Kyritsis AP. (2000). Oncogene, 19, 2-12.
7. Fulci G and Chiocca EA. (2003). Front. Biosci., 8, e346-e360.
8. Glenn GM and Ricciardi RP. (1988). Virus Res., 9, 73-91.
9. Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW and Giaccia AJ. (1996). Nature, 379, 88-91.
10. Griffiths L, Binley K, Iqball S, Kan O, Maxwell P, Ratcliffe P, Lewis C, Harris A, Kingsman S and Naylor S. (2000). Gene Ther., 7, 255-262.
11. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW and Vogelstein B. (1998). Proc. Natl. Acad. Sci. USA, 95, 2509-2514.
12. Ishii N, Maier D, Merlo A, Tada M, Sawamura Y, Diserens AC and Van Meir EG. (1999). Brain Pathol., 9, 469-479.
13. Kirn D. (2001). Gene Ther., 8, 89-98.
14. Koshikawa N, Takenaga K, Tagawa M and Sakiyama S. (2000). Cancer Res., 60, 2936-2941.
15. Kruyt FA and Curiel DT. (2002). Hum. Gene Ther., 13, 485-495.
16. Markert JM, Medlock MD, Rabkin SD, Gillespie GY, Todo T, Hunter WD, Palmer CA, Feigenbaum F, Tornatore C, Tufaro F and Martuza RL. (2000). Gene Ther., 7, 867-874.
17. Modlich U, Pugh CW and Bicknell R. (2000). Gene Ther., 7, 896-902.
18. Parks CL, Banerjee S and Spector DJ. (1988). J. Virol., 62, 54-67.
19. Post DE and Van Meir EG. (2001). Gene Ther., 8, 1801-1807.
20. Prentice H, Bishopric NH, Hicks MN, Discher DJ, Wu X, Wylie AA and Webster KA. (1997). Cardiovasc. Res., 35, 567-574.
21. Ruan H, Su H, Hu L, Lamborn KR, Kan YW and Deen DF. (2001). Neoplasia, 3, 255-263.
22. Ruan H, Wang J, Hu L, Lin CS, Lamborn KR and Deen DF. (1999). Neoplasia, 1, 431-437.
23. Semenza GL. (2000). Genes Dev., 14, 1983-1991.
24. Shibata T, Giaccia AJ and Brown JM. (2000). Gene Ther., 7, 493-498.
25. Talks KL, Turley H, Gatter KC, Maxwell PH, Pugh CW, Ratcliffe PJ and Harris AL. (2000). Am. J. Pathol., 157, 411-421.
26. Tollefson AE, Hermiston TW and Wold WSM. (1999). Adenovirus Methods and Protocols: Methods in Molecular Medicine. In: Wold WSM. (ed). Humana Press: Totowa, pp 1-9.
27. Tsukuda K, Wiewrodt R, Molnar-Kimber K, Jovanovic VP and Amin KM. (2002). Cancer Res., 62, 3438-3447.
28. Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, Zagzag D, Buechler P, Isaacs WB, Semenza GL and Simons JW. (1999). Cancer Res., 59, 5830-5835.